• Health & Medicine

Scottish Medicines Consortium says yes to chemotherapy-free leukaemia treatment

The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia. The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.

8 December 2020

• Health & Medicine

COVID-19 referral drop fears for lung cancer patients in Wales

Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales. Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.

20 November 2020

• Health & Medicine

First ‘targeted’ bowel cancer treatment combo approved for NHS use in England 

The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.   The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.  

20 November 2020

• Health & Medicine

Chemotherapy free treatment for leukaemia given the green light for NHS in England

A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England. A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.

13 November 2020

• Health & Medicine

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

13 November 2020

• Health & Medicine

Immunotherapy drug approved for head and neck cancer

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

26 October 2020

• Policy & Insight

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here's why it's time to invest in cancer services and research. This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here's why it's time to invest in cancer services and research.

20 October 2020

• Policy & Insight

Dear Prime Minister: "Please don't delay action again, we're counting on you"

Campaigner Patrick McGuire writes to Boris Johnson about honouring his manifesto commitments in the upcoming Comprehensive Spending Review. Campaigner Patrick McGuire writes to Boris Johnson about honouring his manifesto commitments in the upcoming Comprehensive Spending Review.

16 October 2020

• Policy & Insight

NHS staff shortages: What’s needed to build a sustainable cancer workforce?

We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%. We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%.

12 October 2020

• Health & Medicine

Lung cancer risks becoming ‘forgotten disease’ of the coronavirus pandemic  

At least 14,000 fewer people have been urgently referred for lung cancer tests since March.  At least 14,000 fewer people have been urgently referred for lung cancer tests since March. 

17 September 2020

• Health & Medicine

Targeted drug for lung cancer approved for NHS use in England

The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer. The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.

11 September 2020

• Health & Medicine

Myeloma maintenance treatment not recommended on NHS in England

Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant. Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.

10 September 2020